A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

Lukas D. Wartman; Mark A. Fiala; Theresa Fletcher; Emily R. Hawkins; Amanda Cashen; John F. DIpersio; Meagan A. Jacoby; Keith E. Stockerl-Goldstein; Iskra Pusic; Geoffrey L. Uy; Peter Westervelt; Ravi Vij

doi:10.3109/10428194.2015.1076930

A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

Lukas D. Wartman, Mark A. Fiala, Theresa Fletcher, Emily R. Hawkins, Amanda Cashen, John F. DIpersio, Meagan A. Jacoby, Keith E. Stockerl-Goldstein, Iskra Pusic, Geoffrey L. Uy, Peter Westervelt, Ravi Vij

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English
Pages (from-to)	728-730
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	57
Issue number	3
DOIs	https://doi.org/10.3109/10428194.2015.1076930
State	Published - Mar 3 2016

Access to Document

10.3109/10428194.2015.1076930

Cite this

Wartman, L. D., Fiala, M. A., Fletcher, T., Hawkins, E. R., Cashen, A., DIpersio, J. F., Jacoby, M. A., Stockerl-Goldstein, K. E., Pusic, I., Uy, G. L., Westervelt, P., & Vij, R. (2016). A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia. Leukemia and Lymphoma, 57(3), 728-730. https://doi.org/10.3109/10428194.2015.1076930

Wartman, Lukas D. ; Fiala, Mark A. ; Fletcher, Theresa ; Hawkins, Emily R. ; Cashen, Amanda ; DIpersio, John F. ; Jacoby, Meagan A. ; Stockerl-Goldstein, Keith E. ; Pusic, Iskra ; Uy, Geoffrey L. ; Westervelt, Peter ; Vij, Ravi. / A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia. In: Leukemia and Lymphoma. 2016 ; Vol. 57, No. 3. pp. 728-730.

@article{0664dafcd103499dba060df818188923,

title = "A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia",

author = "Wartman, {Lukas D.} and Fiala, {Mark A.} and Theresa Fletcher and Hawkins, {Emily R.} and Amanda Cashen and DIpersio, {John F.} and Jacoby, {Meagan A.} and Stockerl-Goldstein, {Keith E.} and Iskra Pusic and Uy, {Geoffrey L.} and Peter Westervelt and Ravi Vij",

note = "Funding Information: Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.",

year = "2016",

month = mar,

day = "3",

doi = "10.3109/10428194.2015.1076930",

language = "English",

volume = "57",

pages = "728--730",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

number = "3",

}

A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia. / Wartman, Lukas D.; Fiala, Mark A.; Fletcher, Theresa; Hawkins, Emily R.; Cashen, Amanda ; DIpersio, John F.; Jacoby, Meagan A.; Stockerl-Goldstein, Keith E.; Pusic, Iskra ; Uy, Geoffrey L.; Westervelt, Peter ; Vij, Ravi.

In: Leukemia and Lymphoma, Vol. 57, No. 3, 03.03.2016, p. 728-730.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

AU - Wartman, Lukas D.

AU - Fiala, Mark A.

AU - Fletcher, Theresa

AU - Hawkins, Emily R.

AU - Cashen, Amanda

AU - DIpersio, John F.

AU - Jacoby, Meagan A.

AU - Stockerl-Goldstein, Keith E.

AU - Pusic, Iskra

AU - Uy, Geoffrey L.

AU - Westervelt, Peter

AU - Vij, Ravi

N1 - Funding Information: Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

PY - 2016/3/3

Y1 - 2016/3/3

UR - http://www.scopus.com/inward/record.url?scp=84945205450&partnerID=8YFLogxK

U2 - 10.3109/10428194.2015.1076930

DO - 10.3109/10428194.2015.1076930

M3 - Letter

C2 - 26674111

AN - SCOPUS:84945205450

VL - 57

SP - 728

EP - 730

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3

ER -

A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

Access to Document

Other files and links

Cite this